1. |
Placenta pathology and microbiology |
2. |
Maternal blood: Kleihauer (in case of anaemia), viral titres (if not previously performed) |
3. |
Maternal vaginal swabs (if not previously performed) |
4. |
Neonatal blood: |
|
4.1 |
Full blood count, coagulation, blood gas, renal and liver biochemistry, glucose, lactate, calcium, magnesium, ammonia, beta-hydroxybutyrate, amino acids, free fatty acids, acylcarnitine profile, urate, uric acid, culture, viral titres, blood spot for cardiolipin analysis |
|
4.2 |
Genetic testing: |
|
|
4.2.1 |
In case of suspicion of unrecognised hypoventilation /apnoea, a sample of DNA should be taken specifically to search for abnormalities of the PHOX2B gene |
|
|
4.2.2 |
Testing for mutations and copy number variation in MECP2 should be considered as it may be revealed as newborn encephalopathy and/or apnoeas and respiratory collapse |
|
|
4.2.3 |
Array-based comparative genomic hybridisation is a useful investigation that will replace conventional karyotyping in the near future as a method for detecting causative chromosomal deletions and duplications |
5. |
Cerebrospinal fluid: biochemistry, culture, virology, lactate, amino acids including glycine |
6. |
Urine: virology, toxicology, organic acids including orotic acid, amino acids including urinary sulphocysteine and urine to be retained for storage |
7. |
Imaging: cranial ultrasound scan, MRI, renal/adrenal ultrasound scan, echocardiogram |
8. |
ECG |
9. |
Ophthalmoscopy |
10. |
Skin biopsy for fibroblast culture |
11. |
Muscle biopsy if unable to exclude neuromuscular or mitochondrial disorder |
12. |
EEG |